CAS NO: | 1361224-53-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | AMG-3969 is a potent glucokinase-glucokinase regulatory protein interaction (GK-GKRP) disruptor with anIC50of 4 nM. | ||||||||||||||||
IC50& Target | IC50: 4 nM (GK-GKRP)[1] | ||||||||||||||||
体外研究 (In Vitro) | AMG-3969 exhibits potent cellular activity with an EC50of 0.202 μM and IC50of 4 nM[1],[2]. It potently reverses the inhibitory effect of GKRP on GK activity and promotes GK translocationin vitro(isolated hepatocytes)[3]. | ||||||||||||||||
体内研究 (In Vivo) | AMG-3969 has goodin vivopharmacokinetic (PK) properties in rats (75%) and significantly lowers blood glucose levels in a dose-dependent mannerdb/dbmice[1]. AMG-3969 (100 mg/kg) demonstrates significant reductions in blood glucose with robust efficacy (56% reduction) observed at the 8 h time point[2]. AMG-3969 demonstrates dose-dependent efficacy in three models of diabetes: diet induced obese (DIO),ob/obanddb/dbmice; however,AMG-3969 is ineffective in lowering blood glucose in normoglycaemic C57BL/6 (B6) mice. AMG-3969 is highly effective in promoting carbohydrate substrate. AMG-3969 exhibits extended changes to carbohydrate oxidation as observed by increased respiratory exchange ratio into the next night and day after a single dose[3]. | ||||||||||||||||
分子量 | 522.46 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C21H20F6N4O3S | ||||||||||||||||
CAS 号 | 1361224-53-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 100 mg/mL(191.40 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|